Finance

Lists
Why is CUE up ७.५३%?
Dive Deeper
CUE:NASDAQ
Cue Biopharma Inc
US$ २०.१४
+७.५३%
(+१.४१) 1D
US$ २०.५०
+१.७९% (+०.३६)
After hours
Closed: नोभेम्बर ९, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CUE...
Open
US$ १८.९०
High
US$ २१.२०
Low
US$ १७.९५
Mkt. cap
१४.६३ करोड
Avg. vol.
१.७५ लाख
Volume
१.८७ लाख
52-wk high
US$ ४५.५०
52-wk low
US$ ४.९७
EPS
-US$ २६.९९
Beta
२.७९
Shares outstanding
७२.६४ लाख
No. of employees
२९
Open
US$ १८.९०
High
US$ २१.२०
Low
US$ १७.९५
Mkt. cap
१४.६३ करोड
Avg. vol.
१.७५ लाख
Volume
१.८७ लाख
52-wk high
US$ ४५.५०
52-wk low
US$ ४.९७
EPS
-US$ २६.९९
Beta
२.७९
Shares outstanding
७२.६४ लाख
No. of employees
२९
News stories
From web sources and news partners
TV News Check
TV News Check
·
५९ मिनेट पहिले
Dow Jumps 1,104; Nasdaq Climbs 674; S&P 500 Adds 173
Investing.com
Investing.com
·
४४ मिनेट पहिले
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.15%
Bloomberg.com
Bloomberg.com
·
२२ घण्टा पहिले
Watch 95% S&P 500, 5% Bitcoin in New Franklin ETF: Drilldown
JournalArta
JournalArta
·
१ घण्टा पहिले
Stock Market Today: S&P 500 Surges 2.35% to 7,549.94 and Nasdaq Jumps 2.74% as Oil Falls and VIX Drops
About Cue Biopharma Inc
CEO-
Employees२९
Founded२०१४
Headquartersबोस्टन, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitecuebiopharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to CUE in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CUE in the last 3 months
Highest
Current US$ २०.१४
US$ ८३.०० (+३१२.१२%)
Average
US$ ८३.०० (+३१२.१२%)
Lowest
US$ ८३.०० (+३१२.१२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mayank Mamtani
B. Riley Securities
Buy
Initiated
US$ ८३.००
+३१२.१%
09/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२१.४९ लाख
२.१९ करोड
५६.८६ लाख
७८.७७ लाख
Cost of goods sold
४१.५४ लाख
१.५९ करोड
६३.९७ लाख
४.८५ करोड
Cost of revenue
४१.५४ लाख
१.५९ करोड
६३.९७ लाख
४.८५ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५५.३९ लाख
४०.५२ लाख
४६.५२ लाख
४.७१ करोड
Operating expense
५५.३९ लाख
४०.५२ लाख
४६.५२ लाख
४.७१ करोड
Total operating expenses
९६.९३ लाख
२.०० करोड
१.१० करोड
९.५६ करोड
Operating income
-७५.४४ लाख
१९.५८ लाख
-५३.६३ लाख
-८.७७ करोड
Other non operating income
-
-
-
-६.५५ करोड
EBT including unusual items
-७४.४८ लाख
२०.८५ लाख
-५१.७८ लाख
-१५.३१ करोड
EBT excluding unusual items
-७३.९७ लाख
२०.६५ लाख
-५१.८८ लाख
-१५.३१ करोड
Income tax expense
-
५.०० लाख
-
-
Effective tax rate
-
२३.९८%
-
-
Other operating expenses
-
-
-
-
Net income
-७४.४८ लाख
१५.८५ लाख
-५१.७८ लाख
-१५.३१ करोड
Net profit margin
-३४६.५८%
७.२२%
-९१.०७%
-१,९४३.२१%
Earnings per share
-२.१०
-
-
-
Interest and investment income
२.२२ लाख
१.५८ लाख
१.७९ लाख
१.५७ लाख
Interest expense
-७५.०० हजार
-५१.०० हजार
-४.०० हजार
-५.०० हजार
Net interest expenses
१.४७ लाख
१.०७ लाख
१.७५ लाख
१.५२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-७४.६४ लाख
२६.३६ लाख
-४७.९७ लाख
-८.७७ करोड
Gain or loss from assets sale
५१.०० हजार
-२०.०० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू